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ABSTRACT
An obstructive ventilatory defect (OVD) is defined by a low forced expiratory volume/‘forced/
slow’ vital capacity (FEV1/FVC) (e.g. <lower limit of normal (LLN)). However, the LLN can be
estimated either by the 90% confidence interval (or the 90th percentile) (American Thoracic and
the European Respiratory Societies (ATS/ERS) method) or by the Z-score (global lung initiative
(GLI) method). In 2014, a new alternative classification (GLI classification) for grading the OVD
severity was proposed to replace the 2005-ATS/ERS one. The aims of the present study were to
determine, according to the two methods (GLI vs. ATS/ERS), the frequency of participants
having an OVD; and to compare the two classifications (GLI vs. ATS/ERS) of OVD severity. This
was a prospective study including 1000 participants (mean age = 41 ± 10 years). The OVD was
defined according to the ATS/ERS [FEV1/FVC < LLN (=local norms value − 1.64 × residual
standard deviation)] and GLI (FEV1/FVC Z-score < −1.64) criteria. The following OVD classifica-
tions severity were applied: ATS/ERS (FEV1%pred): mild (>70%), moderate (60–69%), moderately
severe (50–59%), severe (35–49%), and very severe (<35%) and GLI (FEV1 Z-score): mild (≥ −2.0),
moderate (−2.0 to −2.5), moderately severe (−2.5 to −3.0), severe (−3.0 to −4.0), and very severe
(<−4.0). The frequencies of OVD were 14.4% (ATS/ERS method) and 10.5% (GLI method)
(p < 0.05). Among the 103 participants having an OVD according to the two methods, the
severity classification was mild (34.95% vs. 37.86%, p < 0.05), moderate (25.24% vs. 18.45%,
p < 0.05), moderately severe (23.30% vs. 15.53%, p = 0.144), severe (9.71% vs. 20.39%, p < 0.05),
and very severe (6.80% vs. 7.77%, p = 0.785), respectively for the ATS/ERS and GLI classifications.
The two OVD definitions were not exchangeable. Moreover, the two grading severity systems
misclassified the OVD grades.
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In adults with a prior evidence of lung disease, an
obstructive ventilatory defect (OVD) is usually defined
by a low ratio between the 1st forced expiratory
volume and the ‘forced/slow’ vital capacity [FEV1/(F)
VC] (e.g. <lower limit of normal (LLN)] [1,2]. In prac-
tice, once the OVD diagnosis is retained, it is essential
to grade its severity into five degrees based on the
FEV1 [1,3]. However, nowadays, there is no clear con-
sensus, neither as to what constitutes a LLN, nor as to
how express the FEV1.
Two methods were recommended by the
American Thoracic and the European Respiratory
Societies (ATS/ERS) [1] and by the global lung
initiative (GLI) [2], to estimate the LLN. According
to the ATS/ERS [1], the LLN can be estimated either
as the 90% confidence interval using Gaussian sta-
tistics (in case of normal distribution) or with a
nonparametric technique, such as the 90th percen-
tile (in case of skewed distribution) [1]. In practice,
the 90% LLN of each spirometric data is obtained
by the subtraction of ‘1.64 × residual standard
deviation (SD)’ from the predicted value [1]. For
example, the LLN of FEV1 is equal to ‘FEV1 pre-
dicted value − 1.64 × residual SD’. While according
to the ATS/ERS [1], the aforementioned SD is a
fixed value whatever the age, for the GLI [2], it is
a coefficient of variation that varies with age and,
hence it must be modeled. According to the GLI,
the LLN is considered as a Z-score lower than
‘−1.64’ [2]. The Z-score is derived using the LMS
method [‘L’ for lambda or location (index of skew-
ness), ‘M’ for mu or mean value, and ‘S’ for sigma
or scatter (coefficient of variation)] and using the
generalized additive models for location, scale, and
shape (GAMLSS) technique [4]. The principle of the
LMS method is that the distribution of the out-
come variable Y is defined by three age-varying
parameters λ, µ, σ such that the transformed out-
come: Z = [(Y/µ)λ − 1]/(λ × σ) [5]. The Z-score is
the signed number of SDs by which the value of a
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measured spirometric data differs from the mean
value of what is being predicted, with merely 5%
of healthy subjects having a Z-score of 1.64 or
less [2,6].
The severity of the OVD correlates with the ability
to work and function in daily life, morbidity, respira-
tory complaints, and prognosis, including a fatal out-
come [7]. Surprisingly, there is a disagreement
between the ATS/ERS and the GLI on the way to
express the FEV1 [1,3]. While the ATS/ERS classification
is based on the FEV1 expressed in percentage of the
predicted value (%pred) [1], the GLI new classification
is based on the FEV1 Z-scores [3]. This could be a
source of confusion [6,8].
The present Scientific Letter aimed to ascertain how
well the GLI criteria to diagnosis the OVD [2] and to
grade its severity [3] fit those recommended by the
ATS/ERS [1].
A cross-sectional study including 1000 participants
(145 females) was performed in a private function
exploration center (http://placesmap.net/TN/centre-
international-d-explorations-fonctionnelles-163323/).
Measurements were carried by a plethysmograph
(Jaeger MasterScreen Body, CareFusion Germany).
Local norms [9] were applied to derive the predicted
values and the LLN. The Z-scores were derived for
each participant using norms from the GLI basing
specially on developed software [10]. The OVD was
defined according to the ATS/ERS [FEV1/FVC < LLN
(=local norms value − 1.64 × residual SD) [1]] and
the GLI [FEV1/FVC Z-score < ‘−1.64’ [2]] criteria. The
following two severity classifications were applied:
ATS/ERS [1] [based on the FEV1%pred [11,12]: mild
(>70%), moderate (60–69%), moderately severe (50–
59%), severe (35–49%), and very severe (<35%)]; GLI
[based on the FEV1 Z-score [3]: mild (≥−2.0), moderate
(−2.5 to −2.0), moderately severe (−3.0 to −2.5), severe
(−4.0 to −3.0), and very severe (<−4.0)]. Analyses were
carried out using Statistica software (Statistica Kernel
version 6; StatSoft, Paris, France). Significance was set
at the 0.05 level. Descriptive analysis includes fre-
quencies for categorical variables and mean ± SD for
continuous ones. Chi-square test was used to assess
the agreement between the presence of OVD or its
severity degree according to the two classifications
(GLI vs. ATS/ERS). The relationships between the
three spirometric data (FEV1, FVC, and FEV1/FVC)
expressed as %pred and their Z-scores were evaluated
using the correlation coefficient (r).
The total sample age, height, and weight
mean ± SD were, respectively, 41.29 ± 10.30 years,
1.71 ± 0.08 m, and 80.9 ± 12.2 kg. Twenty percent of
participants were smokers or ex-smokers. The deter-
mined FEV1 (L, %pred), FVC (L, %pred), and FEV1/FVC
(absolute value, %pred) were, respectively, 3.37 ± 0.79
(84 ± 14%), 4.25 ± 0.89 (90 ± 12%), and 0.79 ± 0.08
(97 ± 9%). According to the GLI norms, their
mean ± SD Z-scores were, respectively, −0.87 ± 1.04,
−0.75 ± 0.93, and −0.26 ± 1.04. There were strong and
significant linear relationships between data
expressed as %pred and their Z-scores (r = 0.9280
for FEV1, r = 0.9210 for FVC and r = 0.9689 for FEV1/
FVC). The frequencies of participants having an OVD
were 14.4% and 10.5%, respectively with the ATS/ERS
and the GLI methods (p < 0.05). Conformity of OVD
diagnosis was found in 103 cases. Among the 144
participants having an OVD according to the ATS/
ERS method, 41 were free from OVD according to
the GLI method. Among the 105 participants having
an OVD according to the GLI method, only two were
free from OVD according to the ATS/ERS method.
Moreover, the two grading severity systems misclassi-
fied the grades of OVD (Pearson Chi-square = 214.095,
df = 16, p < 0.05). In fact, for the 103 participants
having OVD according to the ATS/ERS and the GLI
methods, the severity classification was mild (34.95%
vs. 37.86%, p < 0.05), moderate (25.24% vs. 18.45%,
p < 0.05), moderately severe (23.30% vs. 15.53%,
p = 0.144), severe (9.71 vs. 20.39%, p < 0.05), and
very severe (6.80% vs. 7.77%, p = 0.785).
The main result of this study was that the diagnosis
and the classification of the OVD using the GLI
method [2,3] resulted in a change in the frequencies
and the severity degrees established by the ATS/ERS
recommendations [1].
It is conventional that a diagnosis of an OVD
should be based on an abnormally low FEV1/(F)VC
ratio [3]. Unexpectedly, there is no worldwide consen-
sus on what constitutes a low FEV1/(F)VC ratio [3,13].
Whereas the ATS/ERS [1] advocated use of the 5th
percentile of FEV1/(F)VC from a healthy population
as the LLN, the GLI [2] adopted the Z-score value of
FEV1/FVC. According to the GLI [2], unlike %pred the
Z-score is free from bias due to age, height, sex, and
ethnic group. In this study, the two OVD definitions
(GLI vs. ATS/ERS) were not exchangeable. The above
result was contrary to that found in another larger
study (n = 21,191 participants) [3], where the overall
prevalence of OVD was identical with the ATS/ERS [1]
and the GLI [3] definitions. The authors concluded
that this allows reliable reconstruction of ATS/ERS
criterion diagnosis by simple replacement of the LLN
with Z-score [3]. This study findings do not support
the above conclusion and confirmed previous result
that adopting the GLI norms [2] will have significant
effects on the proportions of detection of spirometric
defects [11].
The GLI new classification system was described
as effortless, simply remembered, and clinically con-
vincing [3]. It seems that it retains formerly estab-
lished links with clinical results and circumvents
biases due to the use of FEV1%pred [3]. According
to Quanjer et al. [3], when merged with the GLI
norms [2], it supplies a universal diagnostic
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standard, gratis of bias due to age, height, sex, and
ethnic group. Similar to this study, another one [3]
found a robust linear relationship between FEV1%
pred and FEV1 Z-score (r = 0.99). The authors [3]
concluded that this permits unfailing rebuilding of
ATS/ERS severity classification cut-off values by sim-
ple substitution of FEV1%pred with Z-score. In addi-
tion, they found that using the LLN for FEV1/(F)VC
and Z-scores for FEV1 of −2, −2.5, −3, and −4 to
demarcate severity grades of OVD results in close
arrangement with ATS/ERS severity classifications
[3]. This study finding do not support the above
conclusions. In the cohort study of Tejero et al. [8]
(n = 2614 patients with chronic obstructive pulmon-
ary disease (COPD)), based on ATS/ERS [1] and GLI
[11] classifications, 33.2% and 35.7% had mild,
39.9% and 36.2% had moderate, 18.5% and 20.9%
had severe, and 8.3% and 7.3% had very severe
OVD. Like in this study, in the aforementioned one
[8], the classification based on Z-score [3] showed
little concordance with the ATS/ERS classification
[1]: according to the Z-score classification [3],
66.3% of COPD remained with the same severity,
while 23.7% worsened and 10.0% improved.
The low percentage of females (14.5%) included
in this study, makes the ‘generalization’ of the find-
ings questionable, and a little bit ‘biased’. In order
to avoid such biased assessment of outcomes and
the sex-related effect on spirometric data [14,15], it
was better to include similar percentages of both
sexes. However, the observed low percentage of
females was similar to that reported in a previous
local study where females represented 19.6% of the
total sample [11].
In conclusion, the rational behind the remodeled
scheme for diagnosing OVD and for classifying
spirometric deficiency is interesting. It will afford
the occasion for a universal standard for presenta-
tion and reading of spirometry. However, in some
regions (e.g. North Africa), their application with the
GLI norms should be taken with cautions. Again, the
GLI group [2] is asked to consider North African
population as an individual ethnic group and to
create an adjustment factor for it. A larger number
of North African participants with OVD or COPD will
be needed to analyze the real application of the GLI
[3] adjustment on diagnosing OVD and classifying
its severity.
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